Search Results 2011-2020 of 17080 for monoclonal antibody

1. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

   Hepatitis B core antibody (anti-HBc) positive and who are surface antigen negative, and hepatitis B PCR positive will be excluded; These above patients once ...

2. Science Saturday: Uncovering disparities in local communities - the case of the HPV vaccine - Mayo Clinic News Network

   What can we do about it? Sharing Mayo Clinic: An uncommon antibody, a life restored. Related Articles. Featured News. Harnessing telehealth to enhance patient ...

3. Claudia F. Lucchinetti, M.D.

   Her laboratory is now focused on better understanding the immunological consequences of this antibody on astrocyte function in NMO. Most recently, Dr ...

4. A Study of a Personalized Neoantigen Cancer Vaccine - Mayo Clinic

   Patient has received prior therapy consisting of anti-CTLA-4, anti-PD-1, anti-PD-L1, or any other antibody or drug specifically targeting T-cell co-stimulation ...

5. A Study to Evaluate the Effectiveness of Spesolimab to Treat Hidradenitis Suppurativa - Mayo Clinic

   In case of a positive hepatitis C antibody test, a positive reflex testing for Hepatitis C RNA PCR is considered positive. Major surgery (major according to ...

6. Transplant Medicine News - Medical Professionals - Mayo Clinic

   Use of induction immunosuppression and removal of antibodies that could affect donor hearts allow use of hearts that historically may have been contraindicated.

7. A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer - Mayo Clinic

   Prior treatment with enfortumab vedotin or other monomethyl auristatin E (MMAE)-based antibody-drug conjugates (ADCs);; Uncontrolled diabetes mellitus. MIBC ...

8. A Study to Evaluate NPC-21 to Treat Kidney Transplant Patients at High Risk for Cytomegalorvirus Infection - Mayo Clinic

   Patients who have a positive donor-specific antibody within 90 days prior to Randomization confirmed via medical records. Patients whose body weight is more ...

9. Examining the implications of astrocyte heterogeneity across the brain and spinal cord - Mayo Clinic

   12:e0180697. Receive Mayo Clinic news in your inbox. Sign up. Related Content. Article. Study identifies clinical phenotype, visual outcomes of MOG-IgG antibody ...

10. A Study to Evaluate the Effectiveness and Safety of bb2121 in Subjects with Relapsed and Refractory Multiple Myeloma and in Subjects with Clinical High-Risk Multiple Myeloma - Mayo Clinic

    immunomodulatory agent and an anti-CD38 antibody - Subject has evidence of PD on or within 60 days of the most recent prior treatment regimen - Subject ...